Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque leo mauris, pretium et ipsum quis, convallis ullamcorper sem. Maecenas elementum nibh nisi, eu auctor nunc pulvinar vitae. Donec ut interdum leo. Nam ac felis semper, facilisis nulla venenatis, molestie nibh.
Project leader/senior scientist at UniBern.
2 years in pharma industry.
8 years of research activity on the ECS
Full Professor at UniBern.
Collaboration with pharma industry.
10+ years of research activity on the ECS.
Updated: Nov 6, 2020
From June 9th to June 15th, 2019, Andrea Chicca is in Boston to take part to the Venture Leaders Life Science program: a one week roadshow will help Synendos accelerating its expansion into the US market and building an exceptional business network in the US. https://www.venturelab.ch/Switzerland-Europes-Leading-Life-Science-Hub-Sends-Best-Startups-to-Roadshow-in-the-US
Simon Russell (CCO) is attending the Bio International Convention in Boston from June 16th to June 19th, 2025.
Andrea Chicca (CEO) is attending the Asia Summit on Global Health 2025, in Hong Kong from May 26th to May 27th.
Andrea Chicca (CEO) and Simon Russell (CCO) are attending the BioEquity Europe conference in Bruges from May 12th to May 14th, 2025.